Heart Disease Clinical Trials in Baltimore

Showing 101-120 of 287 trials

Cardiovascular Disease in HIV and Hepatitis C: Risk Outcomes After Hepatitis C Eradication

NCT03823911

This is an interventional, non-randomized, controlled prospective study to treat HCV in mono-infected and HIV co-infected individuals and compare cardiovascular risk outcomes to HIV mono-infected controls. This pilot study will demonstrate whether functional cure of HCV reduces myocardial injury and risk of cardiovascular disease.

Cardiovascular DiseasesHepatitis CHiv

University of Maryland, Baltimore87 participantsStarted Nov 2018

Washington D.C., District of Columbia, United States • Baltimore, Maryland, United States

COMPLETEDPHASE3< 1 mile

RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial

NCT00358215

The purpose of the study is to determine the efficacy of treatment of anemia with darbepoetin alfa compared to placebo on the composite of time to death from any cause or first hospital admission for worsening heart failure in patients with symptomatic left ventricular systolic dysfunction and anemia.

Heart FailureAnemiaCardiovascular Disease+2 more

Amgen2,278 participantsStarted Jun 2006

Birmingham, Alabama, United States • Birmingham, Alabama, United States • Huntsville, Alabama, United States +751 more locations

Cardiovascular Disease in HIV and Hepatitis C: Risk Outcomes After Hepatitis C Eradication

RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial

Heart Disease Trials in Other Cities

Precision Event Monitoring for Patients With Heart Failure Using HeartLogic

Effect of Sotagliflozin on Cardiovascular Events in Participants With Type 2 Diabetes Post Worsening Heart Failure (SOLOIST-WHF Trial)

Vascular Inflammation in Psoriasis - Apremilast

Evaluation of Treatment Strategies for Severe CaLcIfic Coronary Arteries: Orbital Atherectomy vs. Conventional Angioplasty Technique Prior to Implantation of Drug-Eluting StEnts: The ECLIPSE Trial

Telemonitoring to Treat Group 2 Pulmonary Hypertension

Solutions for Atrial Fibrillation Edvocacy (SAFE)

A Study of the Effectiveness of Sitaxsentan Sodium in Patients With Diastolic Heart Failure

Study to Determine Therapeutic Massage Dosing to Improve Quality of Life in Hospitalized Patients Receiving Palliative Care

Physiologic Signals and Signatures With the Accuryn Monitoring System - The Accuryn Registry

SHIELD II Clinical Investigation

Left Atrial Pressure Monitoring to Optimize Heart Failure Therapy

Improving Quality by Maintaining Accurate Problems in the EHR

Chronic Total Occlusion Percutaneous Coronary Intervention Study

Study of Verinurad in Heart Failure With Preserved Ejection Fraction

Access Natriuretic Peptide Assay(s) Pivotal - Emergency Department Subject Enrollment and Specimen Collection

MyLeukoMAP™ Genomic Survival Prediction Assay Pivotal Clinical Study

Single-Ascending Dose Study of JK07 in Subjects With HFpEF

Effect of Adaptive Servo Ventilation (ASV) on Survival and Hospital Admissions in Heart Failure

Other Conditions in Baltimore